Advocacy groups outraged after a PBM offers a $500 gift card to persuade patients to ... The insurer’s pharmacy services unit did so after excluding Cosentyx from four of five different ...

In a letter to doctors in March, some plans run by Cigna Pharmacy said patients could receive a $500 debit card if they switch from Cosentyx to Taltz or an older biologic before Aug. 31 and then ...

If you take Cosentyx, you already might have discovered that your health insurance might no longer cover the injection used to treat the skin disorder psoriasis. Health-care giant Cigna, which ...

Many patients with moderate-to-severe psoriasis retreated with Consentyx regained previous levels of efficacy after 16 weeks following a relapse during a treatment pause, according to a poster ...

Two years ago, she was put on Cosentyx, which is what is known as a biologic disease-modifying anti-rheumatic drug (DMARD). In April, however, CareSource, her insurance provider, stopped approving ...

Novartis has unveiled more positive phase 3 data for Cosentyx, this time in patients with non-radiographic axial spondyloarthritis (nr-axSpA). The Swiss drugmaker has strengthened Consentyx’s ...

Novartis has announced that the Scottish Medicines Consortium has approved Consentyx (secukinumab) to treat adults with active moderate-to-severe hidradenitis suppurativa (HS) in Scotland on the NHS.